Liquidia Corporation Common Stock vs Principal Financial Group Inc Common Stock — how do they compare? Liquidia Corporation Common Stock trades at $34 (market cap $3.04B), while Principal Financial Group Inc Common Stock trades at $108.26 (market cap $22.96B). The key difference: Principal Financial Group Inc Common Stock is far larger — about 7.6× Liquidia Corporation Common Stock's market cap, and Principal Financial Group Inc Common Stock pays a 3.13% dividend while Liquidia Corporation Common Stock pays none. Which is the better fit depends on your goals — on Pluang, investors hold Liquidia Corporation Common Stock for 0 Days and Principal Financial Group Inc Common Stock for 6 Days on average.
| LQDA | PFG | |
|---|---|---|
Market Cap | $3.04B | $22.96B |
Volume | 21,111,778 | 1,305,770 |
Sector | Health | Financials |
52-Week High | $91.03 | $118.51 |
52-Week Low | $22.02 | $78.39 |
Typical Hold Time | 0 Days | 6 Days |
Enterprise Value | $2.94B | $22.04B |
Dividend Yield | — | 3.13% |
Signals from Pluang's Aura AI — not financial advice
No Aura AI signal available yet.
Principal Financial Group (PFG) trades at $107.64, down 0.19% with a bearish technical outlook. The stock shows mixed fundamentals with recent earnings beats but faces valuation concerns at a P/E of 15.33. Recent acquisition of Beam Benefits aims to expand digital capabilities in specialty benefits, while analyst sentiment remains cautious with a 'Hold' consensus rating and $108.33 price target.
PFG presents a balanced risk-reward profile with steady revenue growth and improving profit margins, but faces headwinds from technical weakness and mixed analyst sentiment. The Beam Benefits acquisition provides growth potential in the SMB market, though execution risks and competitive pressures in the multiline insurance sector warrant monitoring for investors seeking exposure to financial services.
Trailing returns across standard periods
What Pluang investors did over the last 30 days
No sentiment data available yet.
Latest headlines on both assets
Liquidia Corporation is a biopharmaceutical company that develops therapies for rare cardiopulmonary diseases, including YUTREPIA, an inhaled treprostinil powder for pulmonary hypertension built on its PRINT technology.
Read more on LQDA →Principal Financial Group provides retirement, insurance, and asset management services. It serves individuals, employers, and institutional clients.
Read more on PFG →